Structure/activity relationships of M2 muscarinic allosteric modulators.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Receptors and Channels

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3109/10606820308264PMID 12893536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic development of high affinity bis(ammonio)alkane-type allosteric enhancers of muscarinic ligand binding.

  2003cited by this paper
• Elevation of ligand binding to muscarinic M(2) acetylcholine receptors by bis(ammonio)alkane-type allosteric modulators.

  2002cited by this paper
• Allosteric binding sites on cell-surface receptors: novel targets for drug discovery

  2002cited by this paper
• Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist.

  2002cited by this paper
• Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands.

  2002cited by this paper
• Lipophilicity and membrane interactions of cationic-amphiphilic compounds: syntheses and structure-property relationships.

  2001cited by this paper
• Hexamethonium‐Type Allosteric Modulators of the Muscarinic Receptors Bearing Lateral Dibenzazepine Moieties

  2001cited by this paper
• Interactions between Allosteric Modulators and 4-DAMP and Other Antagonists at Muscarinic Receptors: Potential Significance of the Distance between the N and Carboxyl C Atoms in the Molecules of Antagonists

  2001cited by this paper
• Effects of brucine, a plant alkaloid, on M(1) muscarinic receptors and alpha(1)-adrenoceptors in the rabbit vas deferens preparation.

  2001cited by this paper
• Stereochemistry of caracurine V.

  2000cited by this paper
• Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site.

  2000cited by this paper
• Structure-activity relationships in a series of bisquaternary bisphthalimidine derivatives modulating the muscarinic M(2)-receptor allosterically.

  2000cited by this paper
• Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors

  2000cited by this paper
• Bisquaternary caracurine V derivatives as allosteric modulators of ligand binding to M2 acetylcholine receptors.

  2000cited by this paper
• Probing the size of a hydrophobic binding pocket within the allosteric site of muscarinic acetylcholine M2-receptors.

  2000cited by this paper
• Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: studies with chimeric receptors.

  2000cited by this paper
• Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts

  2000cited by this paper
• Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors.

  2000cited by this paper
• Subtype‐selective inhibition of [methyl‐3H]‐N‐methylscopolamine binding to muscarinic receptors by α‐truxillic acid esters

  1999cited by this paper
• Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors.

  1999cited by this paper
• Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors.

  1999cited by this paper
• Characterization of the subtype selectivity of the allosteric modulator heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl) ammonium bromide (C7/3-phth) at cloned muscarinic acetylcholine receptors.

  1999cited by this paper
• Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.

  1999cited by this paper
• Bisquaternary ligands of the common allosteric site of M2 acetylcholine receptors: search for the minimum essential distances between the pharmacophoric elements.

  1999cited by this paper
• Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors.

  1999cited by this paper
• Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies.

  1998cited by this paper
• Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.

  1998cited by this paper
• ALLOSTERIC INTERACTIONS AT MUSCARINIC CHOLINOCEPTORS

  1998cited by this paper
• Interaction of ebeinone, an alkaloid from Fritillaria imperialis, at two muscarinic acetylcholine receptor subtypes.

  1997cited by this paper
• Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.

  1997cited by this paper
• Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.

  1997cited by this paper
• Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.

  1997cited by this paper
• Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors.

  1996cited by this paper
• Evidence for a multiple binding mode of bispyridinium-type allosteric modulators of muscarinic receptors.

  1996cited by this paper
• Opposite effects of alcuronium on agonist and on antagonist binding to muscarinic receptors.

  1996cited by this paper
• Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors.

  1996cited by this paper
• Conformational Analysis, Molecular Shape Comparison, and Pharmacophore Identification of Different Allosteric Modulators of Muscarinic Receptors

  1996cited by this paper
• Allosteric regulation of muscarinic receptors.

  1996cited by this paper
• Comparison of structurally different allosteric modulators of muscarinic receptors by self-organizing neural networks.

  1996cited by this paper
• Competitive and allosteric binding of 2 alpha-DHET and its optical isomers to rat cardiac muscarinic receptors.

  1995cited by this paper
• Positive and negative allosteric interactions on muscarinic receptors.

  1995cited by this paper
• Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.

  1995cited by this paper
• Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.

  1995cited by this paper
• Allosteric modulation of muscarinic acetylcholine receptors.

  1995cited by this paper
• Positive allosteric interactions on cardiac muscarinic receptors: effects of chemical modifications of disulphide and carboxyl groups.

  1995cited by this paper
• Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.

  1994cited by this paper
• Protection by Alcuronium of Muscarinic Receptors Against Chemical Inactivation and Location of the Allosteric Binding Site for Alcuronium

  1994cited by this paper
• Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.

  1994cited by this paper
• Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.

  1994cited by this paper
• Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors.

  1994cited by this paper
• Binding of the muscarine receptor antagonist heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at cholinoceptor sites.

  1993cited by this paper
• Two allosteric modulators interact at a common site on cardiac muscarinic receptors.

  1992cited by this paper
• Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes.

  1991cited by this paper
• Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.

  1990cited by this paper
• Comparison between the activities of cationic amphiphilic drugs to affect phospholipid-membranes and to depress cardiac function.

  1989cited by this paper
• Characterization of the antimuscarinic effect of heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl ammonium bromide).

  1989cited by this paper
• Gallamine exerts biphasic allosteric effects at muscarinic receptors.

  1989cited by this paper
• Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.

  1988cited by this paper
• Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication.

  1988cited by this paper
• Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.

  1988cited by this paper
• Verapamil interaction with the muscarinic receptor: stereoselectivity at two sites.

  1987cited by this paper
• Modification of the binding properties of muscarinic receptors by gallamine.

  1983cited by this paper
• THE INHIBITORY EFFECT OF GALLAMINE ON MUSCARINIC RECEPTORS

  1976cited by this paper
• Antimuscarinic action of an alkane-bis-ammonium compound alone and in combination with (+)-benzetimide.

  1975cited by this paper
• Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane-bis-ammonium compounds.

  1969cited by this paper
• Action of atropine and some hexane-1.6-bis-ammonium derivatives upon the toxicity of DFP im mice.

  1968cited by this paper

• Hybridization into a Bitopic Ligand Increased Muscarinic Receptor Activation for Isopilocarpine but Not for Pilocarpine Derivatives.

  2023cites this paper
• Predicting allosteric sites using fast conformational sampling as guided by coarse-grained normal modes.

  2023cites this paper
• Structure-Activity Relationship Study of the High-Affinity Neuropeptide Y4 Receptor Positive Allosteric Modulator VU0506013.

  2023cites this paper
• An allosteric modulator binds to a conformational hub in the β2 adrenergic receptor

  2020cites this paper
• Synergistic regulation mechanism of iperoxo and LY2119620 for muscarinic acetylcholine M2 receptor

  2018cites this paper
• GPCR Dynamics: Structures in Motion.

  2017cites this paper
• Heterodimerization of Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Leads to Increased M2R Affinity and Selectivity

  2017cites this paper
• M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.

  2015cites this paper
• What ligand-gated ion channels can tell us about the allosteric regulation of G protein-coupled receptors.

  2013cites this paper
• Orthosteric Binding of ρ-Da1a, a Natural Peptide of Snake Venom Interacting Selectively with the α1A-Adrenoceptor

  2013cites this paper
• Unexpected salivary secretory effects of some atypical antipsychotics - preclinical studies on clozapine, N-desmethylclozapine, amisulpride and olanzapine

  2013cites this paper
• Activation and allosteric modulation of a muscarinic acetylcholine receptor

  2013cites this paper
• Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.

  2012cites this paper
• Designed multiple ligands: basic research vs clinical outcomes.

  2012cites this paper
• Overview of muscarinic receptor subtypes.

  2012cites this paper
• Structure-activity relationships for a series of M₅ muscarinic receptor modulators

  2011cites this paper
• A Fluorescence Resonance Energy Transfer-based M2 Muscarinic Receptor Sensor Reveals Rapid Kinetics of Allosteric Modulation*

  2010cites this paper
• Allosteric Modulation of Muscarinic Acetylcholine Receptors

  2010cites this paper
• Allosteric Modulation of G Protein Coupled Receptors by Cytoplasmic, Transmembrane and Extracellular Ligands

  2010cites this paper
• Allosteric ligands for G protein‐coupled receptors: A novel strategy with attractive therapeutic opportunities

  2010cites this paper
• Hybrid molecules from xanomeline and tacrine: enhanced tacrine actions on cholinesterases and muscarinic M1 receptors.

  2010cites this paper
• Rational design of dualsteric GPCR ligands: quests and promise

  2010cites this paper
• An optical dynamic mass redistribution assay reveals biased signaling of dualsteric GPCR activators

  2009cites this paper
• Binding of Orthosteric Ligands to the Allosteric Site of the M2 Muscarinic Cholinergic Receptor

  2008cites this paper
• Allosteric interactions at the M3 muscarinic acetylcholine receptor

  2008cites this paper
• Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act?

  2007cites this paper
• Allosteric modulators and selective agonists of muscarinic receptors

  2007cites this paper
• Allosteric Modulation of Muscarinic Acetylcholine Receptors

  2007cites this paper
• Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.

  2007cites this paper
• Muscarinic Allosteric Modulators: Atypical Structure‐Activity‐Relationships in Bispyridinium‐type Compounds

  2006cites this paper
• Allosteric Interactions with Muscarinic Acetylcholine Receptors: Complex Role of the Conserved Tryptophan M2422Trp in a Critical Cluster of Amino Acids for Baseline Affinity, Subtype Selectivity, and Cooperativity

  2006cites this paper
• Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors.

  2006cites this paper
• 6H,13H-Pyrazino[1,2-a;4,5-a']diindole analogs: probing the pharmacophore for allosteric ligands of muscarinic M2 receptors.

  2006cites this paper
• Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist

  2005cites this paper
• Muscarinic allosteric enhancers of ligand binding: pivotal pharmacophoric elements in hexamethonio-type agents.

  2005cites this paper
• Allosteric Binding Sites on Muscarinic Acetylcholine Receptors

  2005influential citation
• Atypical Muscarinic Allosteric Modulation: Cooperativity between Modulators and Their Atypical Binding Topology in Muscarinic M2 and M2/M5 Chimeric Receptors

  2005cites this paper
• Allosterism at muscarinic receptors: ligands and mechanisms.

  2005cites this paper
• Random chemistry as a new tool for the generation of small compound libraries: development of a new acetylcholinesterase inhibitor.

  2005cites this paper
• Muscarinic receptor subtype pharmacology and physiology.

  2005cites this paper
• Cooperative Interactions at M2 Muscarinic Acetylcholine Receptors: Structure/Activity Relationships in Stepwise Shortened Bispyridinium- and Bis(Ammonio)Alkane-Type Allosteric Modulators

  2003cites this paper
• A Novel Class of Allosteric Modulators of the Muscarinic M2 Acetylcholine Receptor: Terphenyl Derivatives

  2003cites this paper